# OnCo record mammaprint (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mammaprint/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mammaprint" ;
  schema:name "MammaPrint (70-gene signature)"@en ;
  schema:description "A 70-gene test that tells whether an early breast cancer is genomically low or high risk, used to decide who can skip chemotherapy."@en ;
  schema:url <https://onco.cc/drugs/mammaprint/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/MammaPrint> ;
  owl:sameAs <http://www.wikidata.org/entity/Q2009487> ;
  schema:citation <https://en.wikipedia.org/wiki/MammaPrint> ;
  onco:status "established" ;
  onco:modality "Gene-expression prognostic assay" ;
  onco:approval "US 2007: FDA 510(k) clearance for recurrence risk in early breast cancer" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-early-high-risk/> ;
  onco:technologies <https://onco.cc/technologies/rna-seq/>, <https://onco.cc/technologies/companion-diagnostic/>, <https://onco.cc/technologies/gene-expression-prognostic-assays/> ;
  onco:companies <https://onco.cc/companies/agendia/> ;
  onco:trials <https://onco.cc/trials/mindact/>, <https://onco.cc/trials/tailorx/> .